New Key Statistics Module, Z-Score and F-Score
NSE:AUROPHARMA Key Ratios
Market Cap ₹ M | 684,727.86 |
Enterprise Value ₹ M | 676,844.46 |
P/E(ttm) | 23.86 |
PE Ratio without NRI | 23.39 |
Forward PE Ratio | -- |
Price/Book | 2.34 |
Price/Sales | 2.40 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 87.33 |
Payout Ratio % | 0.12 |
Revenue (TTM) ₹ M | 275,912.00 |
EPS (TTM) ₹ | 47.25 |
Beneish M-Score | -2.47 |
10-y EBITDA Growth Rate % | 16.00 |
5-y EBITDA Growth Rate % | 3.40 |
y-y EBITDA Growth Rate % | 51.80 |
EV-to-EBIT | 16.41 |
EV-to-EBITDA | 12.01 |
PEG | 6.88 |
Shares Outstanding M | 585.94 |
Net Margin (%) | 10.04 |
Operating Margin % | 13.30 |
Pre-tax Margin (%) | 14.06 |
Quick Ratio | 1.10 |
Current Ratio | 1.81 |
ROA % (ttm) | 6.87 |
ROE % (ttm) | 10.32 |
ROIC % (ttm) | 8.97 |
Dividend Yield % | 0.39 |
Altman Z-Score | 3.75 |
NSE:AUROPHARMA Number of Guru Trades
NSE:AUROPHARMA Volume of Guru Trades
Gurus Latest Trades with NSE:AUROPHARMA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NSE:AUROPHARMA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data